Acousort AB logo

Acousort AB (ACOU)

Market Closed
9 Dec, 15:25
XSTO XSTO
kr
2. 47
-0.18
-6.79%
kr
175.48M Market Cap
- P/E Ratio
0% Div Yield
40,817 Volume
0 Eps
kr 2.65
Previous Close
Day Range
2.43 2.65
Year Range
2.31 13.05
Want to track ACOU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ACOU closed today lower at kr2.47, a decrease of 6.79% from yesterday's close, completing a monthly decrease of -16.27% or kr0.48. Over the past 12 months, ACOU stock lost -77.95%.
ACOU is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2025, missed the consensus estimates by -0.27%. On average, the company has fell short of earnings expectations by -0.19%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSTO (SEK).

ACOU Chart

Similar

Aixia Group AB
kr -
-
Guard Therapeutics International AB
kr 1.38
+3.76%
Corline Biomedical AB
kr 17.2
-1.15%
Index Pharmaceuticals Holding AB
kr 0.56
+3.72%
Biovica International AB
kr -
-

Acousort AB (ACOU) FAQ

What is the stock price today?

The current price is kr2.47.

On which exchange is it traded?

Acousort AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is ACOU.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 175.48M.

Has Acousort AB ever had a stock split?

No, there has never been a stock split.

Acousort AB Profile

Biotechnology Industry
Healthcare Sector
Mr. Torsten Freltoft CEO
XSTO Exchange
SE0009189608 ISIN
Sweden Country
17 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

AcouSort AB (publ) is a pioneering technology company, founded in 2010 and headquartered in Lund, Sweden, which specializes in leveraging acoustofluidics technology for the automated preparation of biological samples. This advanced technological approach allows for efficient and sophisticated handling of cells, extracellular vesicles, bacteria, and viruses, serving the needs of researchers and life science companies alike. AcouSort's innovative solutions are designed to facilitate and expedite the complex processes involved in life sciences research and development, reflecting its commitment to advancing health science through technology. The company's collaboration agreement with a global life science company for the development of cell therapy underscores its position at the forefront of technological advancements and its potential to influence future scientific discoveries.

Products and Services

  • AcouTrap

    A benchtop research instrument developed by AcouSort AB, AcouTrap is engineered for the sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media. Its application is crucial in simplifying the process of isolating biological elements necessary for research, providing researchers with a reliable tool for enhancing laboratory efficiency and accuracy.

  • AcouPlasma

    AcouPlasma serves as an integrated blood plasma separation module that presents a groundbreaking solution for the in-line analysis of blood plasma directly from whole blood samples. This product streamlines the traditionally time-consuming process of plasma separation, enabling quicker analysis and facilitating advancements in diagnostics and research related to blood-based biomarkers.

  • AcouWash

    As a benchtop research instrument, AcouWash is dedicated to the label-free separation of target cells from various samples. This innovative tool significantly contributes to research efficiency, offering a non-invasive method to isolate specific cells for extensive study without the need for external labels or indicators, thereby preserving the natural state of the cells for accurate analysis.

Contact Information

Address: Building 406
Phone: 46 45 20 45 08 54